Tag: small-cap
ALTO Stock Analysis: Buy or Sell? Valuation, Margins & Cash Flow
ALTO is rated Hold as the stock has outrun its earnings base after a 235.6% 52-week gain. The business still produces cash and carries modest leverage, but thin margins leave little room for disappointment.
Rackspace Technology Stock Analysis: Buy or Sell? Leverage & Margins
Rackspace Technology (RXT) is rated Sell as heavy leverage and weak earnings conversion outweigh its hybrid-cloud niche. Despite solid free cash flow, the balance sheet and thin operating margins keep the risk profile elevated.
Lithium Argentina Stock Analysis: Buy or Sell? Cash Flow, Leverage & Valuation
Lithium Argentina AG (LAR) is rated Sell because the market price already reflects a recovery that is not yet showing up in cash flow. Net debt is negative, but levered free cash flow remains negative and valuation still looks demanding versus the current margin profile.
Borr Drilling Stock Analysis: Buy or Sell? Valuation, Leverage & FCF
Borr Drilling Ltd. (BORR) is rated Sell as premium fleet quality has not yet translated into durable equity value. Negative free cash flow, a sharp EBITDA break, and heavy leverage leave the shares vulnerable if dayrates soften again.
Cue Biopharma Stock Analysis: Buy or Sell? Cash Burn, Dilution & Valuation
Cue Biopharma (CUE) is rated Sell as cash burn and dilution risk outweigh the promise of its Immuno-STAT pipeline. A 5.1x EV/revenue valuation and just $27.1 million of year-end cash leave little room for delay before clinical proof arrives.
Range Resources Stock Analysis: Buy or Sell? Valuation, Cash Flow & Gas Risk
Range Resources (RRC) is rated Hold as strong cash generation and a modest balance sheet offset a valuation that already reflects the upside. Its cash flows are solid, but heavy natural-gas exposure keeps the equity tied to commodity pricing.
NexGen Energy Stock Analysis: Buy or Sell? Valuation, Cash Burn & Liquidity
NexGen Energy Ltd. (NXE) is rated Sell as the company is still funding growth ahead of durable cash generation. Despite a recent EBITDA rebound, negative operating cash flow and levered free cash flow keep the investment case dependent on financing and execution.
Altimmune Stock Analysis: Buy or Sell? Valuation, Cash Burn & Phase 3
Altimmune (ALT) is rated Sell as the stock already prices in Phase 3 success while the business remains pre-revenue. Despite $326.3 million in cash and a strong current ratio, negative free cash flow and heavy development spending keep the risk profile elevated.
StubHub Stock Analysis: Buy or Sell? Valuation, FCF & Margins
StubHub Holdings Inc. (STUB) is rated Hold as strong cash generation and a low net debt load are offset by deeply negative EBITDA margins. The marketplace still posts excellent gross margins, but profitability has not yet proven durable enough for a higher rating.
Mama’s Creations Stock Analysis: Buy or Sell? Valuation & Margins
Mama’s Creations (MAMA) is rated Hold as strong revenue growth is already reflected in a rich valuation. Net debt is negative, but thin gross margin and weak free-cash-flow conversion limit upside.